Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey

Icatibant is used to treat acute hereditary angioedema with C1 inhibitor deficiency types I/II (C1‐INH‐HAE types I/II) and has shown promise in angioedema due to acquired C1 inhibitor deficiency (C1‐INH‐AAE). Data from the Icatibant Outcome Survey (IOS) were analysed to evaluate the effectiveness of...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Exp Immunol
Main Authors: Longhurst, H. J., Zanichelli, A., Caballero, T., Bouillet, L., Aberer, W., Maurer, M., Fain, O., Fabien, V., Andresen, I.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2017
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343339/
https://ncbi.nlm.nih.gov/pubmed/27936514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12910
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker